Re:NewCell Past Earnings Performance

Past criteria checks 0/6

Re:NewCell's earnings have been declining at an average annual rate of -52.6%, while the Chemicals industry saw earnings growing at 12.3% annually. Revenues have been growing at an average rate of 95.5% per year.

Key information

-52.6%

Earnings growth rate

-36.4%

EPS growth rate

Chemicals Industry Growth12.4%
Revenue growth rate95.5%
Return on equity-50.3%
Net Margin-195.6%
Next Earnings Update26 Apr 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Re:NewCell makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:6QP Revenue, expenses and earnings (SEK Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 23205-4011990
30 Jun 23124-4082030
31 Mar 2341-3712010
31 Dec 2214-3001850
30 Sep 229-2901900
30 Jun 226-2131590
31 Mar 224-1681300
31 Dec 214-1331030
30 Sep 212-88770
30 Jun 211-80680
31 Mar 212-72610
31 Dec 201-69570
30 Sep 202-60460
31 Dec 191-38320
31 Dec 180-18220

Quality Earnings: 6QP is currently unprofitable.

Growing Profit Margin: 6QP is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 6QP is unprofitable, and losses have increased over the past 5 years at a rate of 52.6% per year.

Accelerating Growth: Unable to compare 6QP's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 6QP is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-34.6%).


Return on Equity

High ROE: 6QP has a negative Return on Equity (-50.32%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies